Han, Xikun https://orcid.org/0000-0002-3823-7308
Gharahkhani, Puya https://orcid.org/0000-0002-4203-5952
Hamel, Andrew R. https://orcid.org/0000-0001-6420-9573
Ong, Jue Sheng https://orcid.org/0000-0002-6062-710X
Rentería, Miguel E. https://orcid.org/0000-0003-4626-7248
Mehta, Puja https://orcid.org/0000-0003-3205-1163
Dong, Xianjun https://orcid.org/0000-0002-8052-9320
Pasutto, Francesca https://orcid.org/0000-0002-0026-5362
Hammond, Christopher https://orcid.org/0000-0002-3227-2620
Young, Terri L. https://orcid.org/0000-0001-6994-9941
Hysi, Pirro https://orcid.org/0000-0001-5752-2510
Lotery, Andrew J. https://orcid.org/0000-0001-5541-4305
Jorgenson, Eric https://orcid.org/0000-0002-5829-8191
Choquet, Hélène https://orcid.org/0000-0001-9839-8667
Hauser, Michael
Cooke Bailey, Jessica N. https://orcid.org/0000-0002-4001-8702
Nakazawa, Toru
Akiyama, Masato https://orcid.org/0000-0002-1879-5476
Shiga, Yukihiro
Fuller, Zachary L.
Wang, Xin https://orcid.org/0000-0001-7242-357X
Hewitt, Alex W. https://orcid.org/0000-0002-5123-5999
Craig, Jamie E.
Pasquale, Louis R. https://orcid.org/0000-0002-5835-3496
Mackey, David A.
Wiggs, Janey L. https://orcid.org/0000-0003-1890-3278
Khawaja, Anthony P. https://orcid.org/0000-0001-6802-8585
Segrè, Ayellet V.
,
,
MacGregor, Stuart https://orcid.org/0000-0001-6731-8142
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (015473, 032559)
Department of Health | National Health and Medical Research Council (1116360)
Article History
Received: 9 March 2022
Accepted: 19 May 2023
First Online: 29 June 2023
Competing interests
: L.R.P. is a consultant to Eyenovia, Twenty Twenty and Skye Bioscience. S.M., J.E.C. and A.W.H. are co-founders of and hold stock in Seonix Pty Ltd. Z.L.F. and X.W. are employed by and hold stock or stock options in 23andMe, Inc. A.P.K. has acted as a paid consultant or lecturer to Abbvie, Aerie, Allergan, Google Health, Heidelberg Engineering, Novartis, Reichert, Santen and Thea. The other authors declare no competing interests.